Merit Medical Systems (NASDAQ:MMSI) Price Target Cut to $90.00 by Analysts at Needham & Company LLC

Merit Medical Systems (NASDAQ:MMSI) had its price objective lowered by Needham & Company LLC from $101.00 to $90.00 in a report released on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the medical instruments supplier’s stock.

Several other equities research analysts also recently weighed in on MMSI. Canaccord Genuity Group decreased their price target on Merit Medical Systems from $99.00 to $90.00 and set a “buy” rating for the company in a report on Tuesday, April 7th. Wall Street Zen downgraded Merit Medical Systems from a “strong-buy” rating to a “buy” rating in a report on Sunday, April 5th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Merit Medical Systems in a report on Friday, March 27th. Compass Point set a $107.00 price target on Merit Medical Systems in a report on Monday, April 20th. Finally, Piper Sandler decreased their price target on Merit Medical Systems from $106.00 to $96.00 and set an “overweight” rating for the company in a report on Friday, April 17th. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $92.80.

Merit Medical Systems Stock Performance

Shares of MMSI stock traded down $6.17 during trading hours on Friday, hitting $62.01. The stock had a trading volume of 2,526,188 shares, compared to its average volume of 579,377. The firm has a market capitalization of $3.70 billion, a PE ratio of 29.25, a PEG ratio of 1.93 and a beta of 0.64. Merit Medical Systems has a twelve month low of $61.31 and a twelve month high of $100.19. The stock’s 50 day moving average is $70.68 and its 200 day moving average is $79.78. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.34 and a quick ratio of 2.95.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings data on Thursday, April 30th. The medical instruments supplier reported $0.94 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.10. The business had revenue of $381.88 million during the quarter, compared to the consensus estimate of $377.59 million. Merit Medical Systems had a return on equity of 13.74% and a net margin of 9.03%.The company’s revenue was up 7.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.86 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. As a group, research analysts forecast that Merit Medical Systems will post 3.61 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of MMSI. Los Angeles Capital Management LLC purchased a new position in Merit Medical Systems in the fourth quarter worth $25,000. Maseco LLP purchased a new position in Merit Medical Systems in the fourth quarter worth $26,000. Salomon & Ludwin LLC purchased a new position in Merit Medical Systems in the third quarter worth $37,000. Torren Management LLC purchased a new position in Merit Medical Systems in the fourth quarter worth $38,000. Finally, Covestor Ltd raised its position in Merit Medical Systems by 252.6% in the fourth quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock worth $41,000 after acquiring an additional 336 shares in the last quarter. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Key Merit Medical Systems News

Here are the key news stories impacting Merit Medical Systems this week:

• Positive Sentiment: Q1 results beat and management raised guidance — Merit reported Q1 non?GAAP EPS of $0.94 (vs. $0.84 est.) and revenue of ~$382M (beat). The company lifted FY2026 EPS guidance to $4.01–$4.15 and reiterated revenue targets, pointing to steady segment/geographic gains and improved margins and free cash flow. Press Release
• Positive Sentiment: Operational highlights support durable cash generation — Management reported GAAP operating margin ~11.6%, non?GAAP operating margin ~19.7%, and free cash flow up ~26%. These metrics support the company’s cash?flow story and capital deployment (recent acquisition activity). Details
• Positive Sentiment: Acquisition expands product set — Merit closed the View Point Medical acquisition (OneMark detection/tissue marker products) for $140M (cash portion $90M), and divested the DualCap line for $28M; these moves can bolster higher?margin therapeutic offerings. Transaction Details
• Neutral Sentiment: Earnings call / transcripts available — Call transcripts and highlights confirm beat and management commentary on organic growth, mix, and margin drivers; useful for investors who want management color. Earnings Call Transcript
• Negative Sentiment: Analysts trimmed price targets — Several firms cut PTs today (JPMorgan: $95?$77, Wells Fargo: $78?$74, Needham: $101?$90). Although ratings were maintained (overweight/equal weight/buy), the cuts reflect multiple?compression or sector re?rating concerns and likely contributed to selling pressure. Analyst Notes (Benzinga)
• Negative Sentiment: Market reaction driven by valuation vs. growth — Despite beats, some analysts flagged growth deceleration and applied lower sector multiples; with the stock already well off its 52?week high, target trims can trigger headline-driven outflows. Analyst Commentary

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.